Orthotic Treatment of Diabetic Foot Ulcers

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05094037
Collaborator
(none)
175
1
2
38.9
4.5

Study Details

Study Description

Brief Summary

The United States Department of Veterans Affairs spends an estimated $1.5 billion a year on healthcare for patients with diabetes. The prevalence and complications of diabetes increase with age. Therefore, with the aging of the US and Veteran populations, there is an expectation of increased healthcare costs associated with treating diabetes and the associated complications of this disorder. One common complication is the diabetic foot ulcer. Diabetic foot ulcers are expensive to treat, can take a long time to heal and result in a decrease in patient quality of life. Patients remain susceptible to developing more foot ulcers over time. The goal of this project is to reduce the time it takes to heal a diabetic foot ulcer, increase the time between episodes of ulceration and improve the quality of life for diabetic foot ulcer patients.

Condition or Disease Intervention/Treatment Phase
  • Device: Removable cam walker boot
  • Other: Counseling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
175 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Other
Official Title:
Orthotic Treatment of Diabetic Foot Ulcers: Patient Adherence to Prescribed Wear and Effectiveness of Treatment
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Sep 2, 2025
Anticipated Study Completion Date :
Mar 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment group

Patients will be given additional counseling

Device: Removable cam walker boot
Standard of care device given to diabetic foot ulcer patients.

Other: Counseling
Additional education, counseling and encouragement of use of the orthosis beyond the current standard of care.

Active Comparator: Control group

Patients will be given standard of care.

Device: Removable cam walker boot
Standard of care device given to diabetic foot ulcer patients.

Outcome Measures

Primary Outcome Measures

  1. Orthosis wear-time [At each clinic visit through study completion, an average of 8 months]

    The total time that the orthosis has been worn between clinic visits.

  2. Foot ulcer size [At each clinic visit through study completion, an average of 8 months]

    Size of the diabetic foot ulcer.

  3. Foot ulcer healing status [At each clinic visit through study completion, an average of 8 months]

    Status of the diabetic foot ulcer.

  4. Number of foot ulcers [At each clinic visit through study completion, an average of 8 months]

    The number of diabetic foot ulcers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Veteran patients prescribed an orthotic walking boot for treatment of their diabetic foot ulcer will be eligible to participate in the study.
Exclusion Criteria:
  • Veteran patients with amputation proximal to the tarsometatarsal joint, with a Meggitt-Wagner score of 4 or more, with severe infection, with non-ambulatory status or without palpable pedal pulse will be excluded

  • All patients will be screened for severe cognitive impairment with the 15 point Brief Interview for Mental Status (BIMS)

  • scores between 12 and 8 will indicate need for extra efforts to support comprehension of instructions, and patients with scores of 7 or less will be excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 Edward Hines Jr. VA Hospital, Hines, IL Hines Illinois United States 60141-5000

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Muturi G. Muriuki, PhD, Edward Hines Jr. VA Hospital, Hines, IL

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT05094037
Other Study ID Numbers:
  • A3781-R
First Posted:
Oct 26, 2021
Last Update Posted:
Aug 8, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2022